Physician profile
Robyn E Pemberton
NPI 1821012238
$751.48
in general payments reported to CMS, 2019-2025
9 companies · $97.60 in 2025
The $97.60 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $416 · 2021: $35.70 · 2022: $44.01 · 2023: $106 · 2024: $52.07 · 2025: $97.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $255.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $438.28 | 2019-2023 | Jornay Pm |
| Sanofi Pasteur INC. | $84.81 | 2021-2023 | |
| Corium, LLC | $64.69 | 2024-2025 | Azstarys |
| Glaxosmithkline, LLC. | $43.61 | 2022-2023 | Bexsero, Rotarix |
| Alk-Abello, INC | $32.58 | 2025 | Grastek, Odactra, Ragwitek |
| Pfizer INC. | $30.31 | 2025 | |
| Verrica Pharmaceuticals INC. | $22.09 | 2024 | Ycanth |
| Merck Sharp & Dohme LLC | $17.84 | 2023 | Proquad, Gardasil 9, M-M-R II |
| Sobi, INC | $17.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robyn Pemberton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.